Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Eyetech Pharmaceuticals Inc (EYET) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Eyetech Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1115285.
Total stock buying since 2005: $0.
Total stock sales since 2005: $771,141.
Total stock option exercises since 2005: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2005 | 0 | $0 | 62,775 | $771,141 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2005-08 | 0 | $0 | 20,925 | $237,186 | 0 | $0 |
| 2005-07 | 0 | $0 | 20,925 | $262,977 | 0 | $0 |
| 2005-06 | 0 | $0 | 20,925 | $270,978 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2005-08-01 | Adamis Anthony P (Chief Scientific Officer) | Sale | 5,325 | 11.35 | 60,438 |
| 2005-08-01 | Guyer David R (Chief Executive Officer) | Sale | 15,600 | 11.33 | 176,748 |
| 2005-07-01 | Adamis Anthony P (Chief Scientific Officer) | Sale | 5,325 | 12.59 | 67,041 |
| 2005-07-01 | Guyer David R (Chief Executive Officer) | Sale | 15,600 | 12.56 | 195,936 |
| 2005-06-01 | Adamis Anthony P (Chief Scientific Officer) | Sale | 5,325 | 12.95 | 68,958 |
| 2005-06-01 | Guyer David R (Chief Executive Officer) | Sale | 15,600 | 12.95 | 202,020 |
Insider trading activities including stock purchases, stock sales, and option exercises of EYET listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Eyetech Pharmaceuticals Inc (symbol EYET, CIK number 1115285) see the Securities and Exchange Commission (SEC) website.